Former Pharmaceuticals Director Martin Shkreli was sentenced to life in prison by the industry and sentenced to pay a $ 64.6 million fine, according to a federal judge’s ruling Friday.
Shkreli was sued in January 2020 for allegedly violating antitrust rules to set the price of the drug Daraprim and delaying “the entry into generic competition for at least eighteen months,” according to the verdict.
U.S. District Judge Denise Cote said in a 135-page verdict that Shkreli’s “sinister, deliberate, repetitive, prolonged and ultimately dangerous illegal behavior” justified the harsh punishment.
The so-called “Pharma Bridge” has previously been convicted of securities fraud and is serving seven years in prison. He is also facing a new lawsuit filed last year by health insurance companies accusing him of illegally raising the price of a life-saving drug.
This story is evolving. Please come back for updates.